Instanyl DoseGuard Nasal Spray device
Winner
Excellent Product Design
Medical, Rehabilitation and Health Care

Credits
Company / Customer
Details
The Instanyl DoseGuard is a novel electronic nasal lockout device developed by Takeda and Aptar Pharma to address drug overuse in cancer patients. It limits the number of doses a patient can take within a normal dosing regime & automatically locks after delivering two doses within an hour, preventing overuse and misuse. The device is user-friendly for senior patients and has a child-resistant cap for added safety. The packaging is recyclable, Takeda has set up a take-back program for recycling.
The Jury‘s Statement
Thanks to its ergonomic design, the "Instanyl DoseGuard" allows the nasal spray to be used comfortably. At the same time, the integrated technology ensures that only a certain amount can be taken per time unit, which prevents overdosing and misuse of medication. The fact that the empty packaging is part of a recycling programme and is taken back by the manufacturer is sustainable.




